A new way to fight antibiotic-resistant bacteria

September 20, 2013 by Suzanne Morrison

At a time when scientists are quickly running out of options, McMaster researchers are using a new approach to fighting antibiotic-resistant bacteria.

The technique involves researchers in the Michael G. DeGroote Institute for Infectious Disease Research targeting the cell membranes of MRSA—a bacteria responsible for increasing the number of life-threatening infections both in hospitals and communities.

"Bacterial membranes have been relatively unexplored as targets for because of concerns of the potential for toxicity of membrane-active drugs," said Eric Brown, a professor in the Department of Biochemistry and Biomedical Sciences.

Brown ultimately followed a suggestion from one of his students, Maya Farha. She suggested targeting bacterial membranes with various combinations of membrane-active chemicals that show synergy. In other words, two that together would have a greater effect and avoid toxicity.

"The bacterial membrane is a for energy production and storage in bacteria that functions like a battery," said Brown. "We sought out two classes of chemicals in this work that could disrupt the 'bacterial battery' and found that when we combined them, they were wildly synergistic. Voila, a dead battery means no energy in the cell. And a bacterium with no energy is a dead bacterium."

The McMaster discovery is an important one, because antibiotic-resistant bacteria are a growing worldwide. Scientists have been warning that the weakening arsenal against so-called "superbugs" could mean everyday infections could again become a major cause of death—just as they were before the discovery and development of penicillin in the late 1930s by the likes of Alexander Fleming.

"Every day, we are thinking about new ways to address this problem … and trying to take an innovative approach," said Brown.

The World Health Organization (WHO) estimates the total cost of treating all hospital-borne antibiotic-resistant infections is about $10 billion a year. Tuberculosis, gonorrhea, malaria and childhood ear infections are just a few of the diseases that have become hard to treat with antibiotic drugs, largely because of overuse.

The research will appear in the Sept. 19 edition of Chemistry & Biology.

Explore further: Using 'bacteria-eaters' to prevent infections on medical implant materials

Related Stories

Biologists develop new method for discovering antibiotics

September 16, 2013

Biologists at the University of California, San Diego have developed a revolutionary new method for identifying and characterizing antibiotics, an advance that could lead to the discovery of new antibiotics to treat antibiotic ...

Recommended for you

Brazilian wasp venom kills cancer cells by opening them up

September 1, 2015

The social wasp Polybia paulista protects itself against predators by producing venom known to contain a powerful cancer-fighting ingredient. A Biophysical Journal study published September 1 reveals exactly how the venom's ...

Naturally-occurring protein enables slower-melting ice cream

August 31, 2015

(Phys.org)—Scientists have developed a slower-melting ice cream—consider the advantages the next time a hot summer day turns your child's cone with its dream-like mound of orange, vanilla and lemon swirls with chocolate ...

Antibody-making bacteria promise drug development

August 31, 2015

Monoclonal antibodies, proteins that bind to and destroy foreign invaders in our bodies, routinely are used as therapeutic agents to fight a wide range of maladies including breast cancer, leukemia, asthma, arthritis, psoriasis, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.